Data from the Investor Presentation & this is what is causing all the excitement. Treatment then rechallenge with the tumour:
And then if you want to look at potential collaborations/partnerships in solid tumours & the cancer cell lines addressed by CF-33 (>60 as stated by LC in the interview), that these CAR T treatments are (not yet) able to treat (can see the effect on tumour above in the graphs). Pre-clinical yes, but shortly we will see CF33 in the clinic in Ph1.
Apologies for rambling on, but this puts into perspective the lastest interview LC did (posted by @Oxxa on the media thread) & had read through all of this before listening. Just amazing!! GLTAH
Ann: Investor Presentation, page-16
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.003(5.08%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $2.898M | 51.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 4186955 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 337877 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |